Octave Bioscience
Octave Bioscience is a biotech company in Menlo Park, United States, founded in 2014. It has raised $81.6M across 3 rounds, most recently a $35.6M Series C in September 2025.
Home - OctaveBio
- Headquarters
- Menlo Park, California
- Employees
- 51–200
- Founded
- 2014
- Website
- octavebio.com
- Total Funding
- $81.6M
- Last Round
- $35.6M Series CSep 2025
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.
About
Octave develops blood-based biomarker tests that illuminate the path forward for patients with neurodegenerative diseases, starting with multiple sclerosis.
Summary
It lists 51–200 employees. It has raised $81.6M in total across 3 rounds, most recently a $35.6M Series C round in Sep 2025. Investors include Silicon Valley Bank, BlueCross BlueShield Venture Partners and Echo Health Ventures.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Sign up to see all 4 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/octave-bioscience"><img src="https://indexed.vc/api/badge/company/octave-bioscience" alt="Octave Bioscience on Indexed.vc" width="260" height="76" /></a>